research article
Boosting dendritic cell nanovaccines
April 11, 2022
A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.
Type
research article
Web of Science ID
WOS:000780825800003
Author(s)
Date Issued
2022-04-11
Publisher
Published in
Volume
17
Start page
442
End page
444
Editorial or Peer reviewed
REVIEWED
Written at
EPFL
EPFL units
Available on Infoscience
April 25, 2022
Use this identifier to reference this record